Literature DB >> 4285574

Experiences in developing potential antiviral compounds.

J R Dice, W A Rightsel, F M Schabel, I W McLean.   

Abstract

Mesh：

Substances：

Year:  1965        PMID： 4285574     DOI： 10.1111/j.1749-6632.1965.tb12535.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

Authors:  B J Owens; G M Anantharamaiah; J B Kahlon; R V Srinivas; R W Compans; J P Segrest
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Antiviral activity of carbobenzosy di- and tripeptides on measles virus.

Authors:  F A Miller; G J Dixon; G Arnett; J R Dice; W A Rightsel; F M Schabel; I W McLean
Journal:  Appl Microbiol       Date:  1968-10

3.  Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees.

Authors:  N L Shipkowitz; R R Bower; J B Schleicher; F Aquino; R N Appell; W R Roderick
Journal:  Appl Microbiol       Date:  1972-01

4.  Indirect mouse model for the evaluation of potential antiviral compounds: results with Venezuelan equine encephalomyelitis virus.

Authors:  R W Kuehne; W L Pannier; E L Stephen
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.